Similar articles

• Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo model.

  Mulder LC, Mora M, Lazzeri M, Boschi M, Ciccopiedi E, Melli C, Bruzzone P, Alfani D. Mulder LC, et al. Transplant Proc. 1996 Apr;28(2):589. Transplant Proc. 1996. PMID: 8623287 No abstract available.
• Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.

  Mulder LC, Mora M, Lazzeri M, Boschi M, Ciccopiedi E, Marinucci G, Melli CM, Bruzzone P, Alfani D, Cortesini R, Rossini M. Mulder LC, et al. Transplant Proc. 1996 Feb;28(1):127-9. Transplant Proc. 1996. PMID: 8644143 No abstract available.
• High-level tissue specific expression of human CD59, MCP, and DAF proteins from genomic clones in transgenic mice.

  Oldham ER, Velardo MA, Platt JL, Logan JS, Diamond L. Oldham ER, et al. Transplant Proc. 1996 Apr;28(2):693. Transplant Proc. 1996. PMID: 8623349 No abstract available.
• Immunization against tumor cell surface complement-regulatory proteins.

  Durrant LG, Spendlove I. Durrant LG, et al. Curr Opin Investig Drugs. 2001 Jul;2(7):959-66. Curr Opin Investig Drugs. 2001. PMID: 11757799 Review.
• [Complement regulatory factors and immunologic recognition mechanism between species].

  Seya T, Matsunoto M. Seya T, et al. Nihon Rinsho Meneki Gakkai Kaishi. 1995 Dec;18(6):637-42. Nihon Rinsho Meneki Gakkai Kaishi. 1995. PMID: 8963770 Review. Japanese. No abstract available.